Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1643
This examiner grants 21% of resolved cases
Erin Virginia Paulus, an examiner in Tech Center 1600 and Art Unit 1631, has 19 resolved cases. The allowance rate is 21.1%, which reflects the percentage of cases that have reached a grant. The median days to allowance for these cases is 1265. This 1265-day figure serves as a benchmark for the time required to achieve a successful outcome in this unit.
The interview lift is 93.8%, which is a notable metric in this profile. A 93.8% lift indicates that interviews are a highly effective method for increasing the probability of an allowance. This 93.8% lift is much higher than the 21.1% allowance rate, suggesting that verbal engagement is a critical factor for success. With 19 resolved cases, the data provides a focused look at the examiner's tendencies. Practitioners should prioritize interviews to leverage the 93.8% lift and address the challenges indicated by the 21.1% allowance rate. The 1265-day median to allowance is a useful reference for managing the prosecution timeline in Art Unit 1631.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18174096 | METHOD OF RECOVERING CELLS AND CELL RECOVERY APPARATUS | Final Rejection | CANON KABUSHIKI KAISHA |
| 17801408 | COMPOSITION FOR INDUCING BROWNING, CONTAINING MILK EXOSOMES | Final Rejection | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY |
| 18394297 | COMPOSITIONS AND METHODS FOR AMELIORATING ANTERODORSAL THALAMUS HYPEREXCITABILITY | Non-Final OA | Massachusetts Institute of Technology |
| 18033470 | METHODS FOR PROCESSING FETAL SUPPORT TISSUE | Final Rejection | BioTissue Holdings Inc. |
| 18279034 | STRATEGIES TO DEVELOP GENOME EDITING SPHERICAL NUCLEIC ACIDS (SNAS) | Non-Final OA | NORTHWESTERN UNIVERSITY |
| 18544063 | COMPOSITIONS AND METHODS FOR EXTENDING THE REPLICATIVE CAPACITY OF BOVINE CELLS | Non-Final OA | Upside Foods, Inc. |
| 18317526 | Rapidly synthesized extracellular matrix-based gels and patterning techniques, from micro- to macro-scale | Non-Final OA | Yale University |
| 18044667 | METHOD FOR QUICKLY AND EFFICIENTLY DIFFERENTIATING FUNCTIONAL GLIAL CELLS | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 18053949 | Method and System for Area-Specific Tissue Collection and Analysis | Non-Final OA | The Florida State University Research Foundation, Inc. |
| 17876993 | Method of Demineralizing Bone with an Ionic Solution | Final Rejection | Newsouth Innovations Pty Limited |
| 18553295 | Gene Therapy for Retinal Disease | Non-Final OA | OXFORD UNIVERSITY INNOVATION LIMITED |
| 18033639 | MODIFIED SIGNAL PEPTIDE | Final Rejection | KAO CORPORATION |
| 18271503 | PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS | Final Rejection | Ecole Polytechnique Federale de Lausanne (EPFL) |
| 18480306 | NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE | Non-Final OA | The United States of America, as represented by the Secretary, Dept. of Health and Human Services |
| 18568851 | METHOD FOR MANUFACTURING PERIPHERAL NERVE-MIMICKING MICROTISSUE AND USES THEREOF | Final Rejection | INNOSTEM BIO |
| 18424292 | COMPOUNDS AND METHODS FOR TREATMENT OF DIAMOND BLACKFAN ANEMIA | Final Rejection | THE CHILDREN'S MEDICAL CENTER CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy